These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4398920)

  • 1. Antihypertensive and monoamine oxidase inhibitory activity of some derivatives of 3-formyl-4-oxo-4H-pyrido (1,2-a) pyrimidine.
    George T; Kaul CL; Grewal RS; Tahilramani R
    J Med Chem; 1971 Oct; 14(10):913-5. PubMed ID: 4398920
    [No Abstract]   [Full Text] [Related]  

  • 2. antihypertensive and monoamine oxidase inhibitory activity of some azacycloalkyl-substituted benzaldehyde hydrazone derivatives.
    George T; Kaul CL; Grewal RS; Mehta DV
    J Med Chem; 1971 Oct; 14(10):909-13. PubMed ID: 4398919
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

  • 4. Some puzzling pharmacological effects of monoamine oxidase inhibitors.
    Knoll J; Magyar K
    Adv Biochem Psychopharmacol; 1972; 5():393-408. PubMed ID: 5066229
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic and "antiadrenergic" actions of prenylamine.
    Grobecker H; Palm D; Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):174-6. PubMed ID: 4232664
    [No Abstract]   [Full Text] [Related]  

  • 6. On the pharmacology of guanoxan.
    Vidal-Beretervide K; Pritsch LE; Trinidad H
    Arzneimittelforschung; 1969 Jun; 19(6):947-51. PubMed ID: 4389903
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the pharmacology of prenylamine].
    Grobecker H; Palm D; Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(5):379-99. PubMed ID: 4387688
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of pyrido[1,2-a]pyrimidin-4-ones. Potential antihypertensive agents. III.
    Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A
    Farmaco Sci; 1986 Dec; 41(12):926-33. PubMed ID: 3556566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of Go-1002.
    Grewal RS; Kaul CL; David J
    J Pharmacol Exp Ther; 1968 Apr; 160(2):268-76. PubMed ID: 4384786
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyrrolo(4,3,2-de)isoquinolines with central nervous system and antihypertensive activities.
    Demerson CA; Philipp AH; Humber LG; Kraml MJ; Charest MP; Tom H; Vávra I
    J Med Chem; 1974 Nov; 17(11):1140-5. PubMed ID: 4415412
    [No Abstract]   [Full Text] [Related]  

  • 12. The antihypertensive properties of 1-amino-4-phenyl pyridinium chloride.
    Cullum VA; Farmer JB; Handley SL
    Br J Pharmacol Chemother; 1967 Nov; 31(3):435-46. PubMed ID: 4295635
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis and pharmacodynamic properties of various lupinane derivatives].
    Sparatore F; Boido V; Preziosi P; Miele E; De Natale G
    Farmaco Sci; 1969 Jun; 24(6):587-621. PubMed ID: 4390006
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E-250).
    Magyar K; Vizi ES; Ecseri Z; Knoll J
    Acta Physiol Acad Sci Hung; 1967; 32(4):377-87. PubMed ID: 5595908
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacological effects of an unusual hypotensive agent: (SK & F 11197, 2,6-diamino-4-dimethylamino-ethoxy pyrimidine). I. Effects on the cardiovascular system.
    Ehrreich SJ; Heringslake JE; Warren FR; Weinstock J; Tedeschi RE
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):284-302. PubMed ID: 5367304
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of bethanidine on response to ergotamine and noradrenaline.
    Follenfant M; Green AF
    Br J Pharmacol; 1970 May; 39(1):225P-226P. PubMed ID: 4392964
    [No Abstract]   [Full Text] [Related]  

  • 17. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.
    Boissier JR; Giudicelli JF; Fichelle J; Schmitt H; Schmitt H
    Eur J Pharmacol; 1968 Mar; 2(5):333-9. PubMed ID: 5663498
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of actions of catecholamines by a derivative of hemicholinium.
    Wong S; Long JP
    J Pharmacol Exp Ther; 1967 Jun; 156(3):469-82. PubMed ID: 4381801
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypotensive activity of beta-heptamethylenimino-ethylaminoguanidine sulfate.
    Botton I; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 May; 152(2):243-50. PubMed ID: 5944368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.